23285048|t|Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.
23285048|a|Delta-like 4 (Dll4) is a ligand of the Notch pathway family which has been widely studied in the context of tumor angiogenesis, its blockade shown to result in non-productive angiogenesis and halted tumor growth. As Dll4 inhibitors enter the clinic, there is an emerging need to understand their side effects, namely the systemic consequences of Dll4:Notch blockade in tissues other than tumors. The present study focused on the effects of systemic anti-Dll4 targeting in the bone marrow (BM) microenvironment. Here we show that Dll4 blockade with monoclonal antibodies perturbs the BM vascular niche of sub-lethally irradiated mice, resulting in increased CD31(+), VE-Cadherin(+) and c-kit(+) vessel density, and also increased megakaryocytes, whereas CD105(+), VEGFR3(+), SMA(+) and lectin(+) vessel density remained unaltered. We investigated also the expression of angiocrine genes upon Dll4 treatment in vivo, and demonstrate that IGFbp2, IGFbp3, Angpt2, Dll4, DHH and VEGF-A are upregulated, while FGF1 and CSF2 are reduced. In vitro treatment of endothelial cells with anti-Dll4 reduced Akt phosphorylation while maintaining similar levels of Erk 1/2 phosphorylation. Besides its effects in the BM vascular niche, anti-Dll4 treatment perturbed hematopoiesis, as evidenced by increased myeloid (CD11b(+)), decreased B (B220(+)) and T (CD3(+)) lymphoid BM content of treated mice, with a corresponding increase in myeloid circulating cells. Moreover, anti-Dll4 treatment also increased the number of CFU-M and -G colonies in methylcellulose assays, independently of Notch1. Finally, anti-Dll4 treatment of donor BM improved the hematopoietic recovery of lethally irradiated recipients in a transplant setting. Together, our data reveals the hematopoietic (BM) effects of systemic anti-Dll4 treatment result from qualitative vascular changes and also direct hematopoietic cell modulation, which may be favorable in a transplant setting.
23285048	39	51	Delta-like 4	GeneOrGeneProduct	54485
23285048	99	111	Delta-like 4	GeneOrGeneProduct	54485
23285048	113	117	Dll4	GeneOrGeneProduct	54485
23285048	138	143	Notch	GeneOrGeneProduct	18128
23285048	207	212	tumor	DiseaseOrPhenotypicFeature	D009369
23285048	298	303	tumor	DiseaseOrPhenotypicFeature	D009369
23285048	315	319	Dll4	GeneOrGeneProduct	54485
23285048	445	449	Dll4	GeneOrGeneProduct	54485
23285048	450	455	Notch	GeneOrGeneProduct	18128
23285048	487	493	tumors	DiseaseOrPhenotypicFeature	D009369
23285048	553	557	Dll4	GeneOrGeneProduct	54485
23285048	628	632	Dll4	GeneOrGeneProduct	54485
23285048	727	731	mice	OrganismTaxon	10090
23285048	756	760	CD31	GeneOrGeneProduct	18613
23285048	765	776	VE-Cadherin	GeneOrGeneProduct	12562
23285048	784	789	c-kit	GeneOrGeneProduct	16590
23285048	852	857	CD105	GeneOrGeneProduct	13805
23285048	862	868	VEGFR3	GeneOrGeneProduct	14257
23285048	873	876	SMA	GeneOrGeneProduct	11475
23285048	884	890	lectin	GeneOrGeneProduct	-
23285048	990	994	Dll4	GeneOrGeneProduct	54485
23285048	1035	1041	IGFbp2	GeneOrGeneProduct	16008
23285048	1043	1049	IGFbp3	GeneOrGeneProduct	16009
23285048	1051	1057	Angpt2	GeneOrGeneProduct	11601
23285048	1059	1063	Dll4	GeneOrGeneProduct	54485
23285048	1065	1068	DHH	GeneOrGeneProduct	13363
23285048	1073	1079	VEGF-A	GeneOrGeneProduct	22339
23285048	1103	1107	FGF1	GeneOrGeneProduct	14164
23285048	1112	1116	CSF2	GeneOrGeneProduct	12981
23285048	1180	1184	Dll4	GeneOrGeneProduct	54485
23285048	1193	1196	Akt	GeneOrGeneProduct	11651
23285048	1249	1256	Erk 1/2	GeneOrGeneProduct	26413,26417
23285048	1325	1329	Dll4	GeneOrGeneProduct	54485
23285048	1400	1405	CD11b	GeneOrGeneProduct	16409
23285048	1424	1428	B220	GeneOrGeneProduct	19264
23285048	1440	1443	CD3	GeneOrGeneProduct	12501
23285048	1479	1483	mice	OrganismTaxon	10090
23285048	1560	1564	Dll4	GeneOrGeneProduct	54485
23285048	1670	1676	Notch1	GeneOrGeneProduct	18128
23285048	1692	1696	Dll4	GeneOrGeneProduct	54485
23285048	1889	1893	Dll4	GeneOrGeneProduct	54485
23285048	Positive_Correlation	54485	12501	Novel
23285048	Positive_Correlation	54485	19264	Novel
23285048	Negative_Correlation	54485	16409	Novel
23285048	Association	54485	11651	Novel
23285048	Association	54485	D009369	No
23285048	Association	54485	18128	Novel
23285048	Positive_Correlation	54485	12981	Novel
23285048	Positive_Correlation	54485	14164	Novel
23285048	Positive_Correlation	54485	22339	Novel
23285048	Positive_Correlation	54485	13363	Novel
23285048	Positive_Correlation	54485	11601	Novel
23285048	Positive_Correlation	54485	16009	Novel
23285048	Positive_Correlation	54485	16008	Novel
23285048	Association	54485	16590	Novel
23285048	Association	54485	12562	Novel
23285048	Association	54485	18613	Novel